Skip to main content

Table 8 Levels of mRNA transcription vs outcome

From: Lymphangiogenesis and lymph node metastasis in breast cancer

  ALIVE AND WELL RECURRENCE p-VALUE
LYVE-1 79.1 ± 389.0 (65) 6.1 ± 11.0 (23) 0.932
PROX-1 4568.0 ± 6729.0 (84) 7420.0 ± 12336 (31) 0.076
Podoplanin 13605.0 ± 78024 6550 9336.0 ± 15008.0 (31) 0.186
5'Nuceotidase 4230.0 ± 6550.0 (78) 8091.0 ± 14398.0 (29) 0.203
VEGFR-3 113.0 ± 229.0 (85) 149.0 ± 227.0 (31) 0.064
VEFG-C 1124.0 ± 464.0 (60) 3919.0 ± 3370.0 (22) 0.660
VEGF-D 47.9 ± 17.1(44) 60.3 ± 24.5 (12) 0.881
VEGFR-2 5.5 ± 15.2 (83) 4.1 ± 99.0 (29) 0.375
VEGFC:VEGF-D ratio 148.0 ± 78.0 108.0 ± 106.0 0.77
  1. Please note for all tables, the number in parentheses gives the number of samples valid for analysis following PCR.